Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
While Royal Philips Electronics recorded a net income of 200 million ($270.8 million U.S.) for the 2010 first quarter compared with a net loss of 59 million ($79.5 million U.S.) in the 2009 first quarter, Philips Healthcare also saw a 20 percent growth in equipment order intake.
Spacelabs Healthcare has released Ultraview DM3, which provides caregivers with a dual-mode technology for measuring vital signs (SpO2, pulse rate, non-invasive blood pressure, respiration and temperature) on adult and pediatric patients.
Congress passed the Continuing Extension Act of 2010 earlier this week. As widely reported, the bill extends unemployment insurance and postpones the 21 percent cut in physician reimbursement under Medicare until June 1. Another section of the bill has received less coverage, but is just as significant for a multitude of practitionersthe EHR Clarification language for qualification for clinic-based physicians.
Americans who have access to their health information through personal health records (PHRs) report that they know more about their health, ask more questions and take better care of themselves than when their medical information was less accessible to them in paper records, according to a survey from the California HealthCare Foundation (CHCF).
Verizon Wireless, BL Healthcare and a number of customers and third-party providers will jointly trial products for the delivery of remote healthcare applications and services to patients.
Revenues from remote patient monitoring using mobile networks will rise to almost $1.9 billion globally by 2014, with heart-based monitoring in the U.S. accounting for the bulk of early mobile monitoring roll-outs, according to market research firm Juniper Research.
Vasomedical, which develops non-invasive treatment for the management of cardiovascular diseases, has received FDA 510(k) clearance to market its Vasomedical-BIOX Model 2301 Combined ECG Holter and ambulatory blood pressure monitoring recorder and software analysis system.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
